CAR T Therapy Is Becoming More Decentralized and Patient Centered – City of Hope
City of Hope shared a post on LinkedIn:
“The delivery of cell therapies is evolving faster than many realize.
CAR T and other cellular treatments are expected to become more decentralized in 2026, with care shifting into outpatient clinics and select home-based settings.
This transition, supported by remote monitoring and digital health, has the potential to significantly reduce hospital stays, lower overall costs and expand access to complex cancer therapies.
Eileen Smith, M.D., the Francis and Kathleen McNamara Distinguished Chair and Professor, Department of Hematology and Hematopoietic Cell Transplantation, outlines how City of Hope‘s model, developing cell therapies on site and delivering care beyond inpatient settings, is helping set a new national standard for patient-centered treatment.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 16:51Suzan Nakasendwa: A Growing Stroke Challenge in Uganda
-
Oct 20, 2026, 16:38Steve Moon: How Does Smoking Cessation Duration Affect Ischemic Stroke Risk
-
Oct 20, 2026, 16:25Cedrice Mentor: Reducing Platelet Wastage Through Cold Storage
-
Oct 20, 2026, 16:09Thirunavukkarasu Angappan: Can a Purified Fibrinogen Concentrate Replace Cryoprecipitate
-
Oct 20, 2026, 16:01Kalyan Roy: Platelet Conservation Through Evidence-Based Transfusion Practice
-
Oct 20, 2026, 15:28Stacy E. Croteau: 33 Countries, One Mission – Better Bleeding Disorder Care
-
Oct 20, 2026, 15:19Teresa Barnes: What Does a Pulmonary Embolism Mean for Jalen Hurts?
-
Oct 20, 2026, 15:04Laura S.: Could Speaking Up Prevent Maternal Deaths from Thrombosis?
-
Oct 20, 2026, 14:44Pete Stibbs: VTE in Professional Athletes – When Fitness Is Not Enough